Published in Surg Gynecol Obstet on October 01, 1981
Evolution of liver transplantation. Hepatology (1982) 19.54
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids. Surg Gynecol Obstet (1982) 2.42
Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol (1988) 2.21
Current status of hepatic transplantation. Semin Liver Dis (1983) 1.75
Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74
Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62
Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr (1982) 1.54
Causes of death after kidney transplantation. JAMA (1983) 1.38
Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation (1981) 1.38
Cadaveric renal transplantation under cyclosporine-steroid therapy. Surg Gynecol Obstet (1983) 1.29
Liver transplantation in the ciclosporin era. Prog Allergy (1986) 1.14
CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry (1993) 1.07
Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc (1985) 1.04
Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin Exp Immunol (1983) 0.98
99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. Radiology (1982) 0.95
Steps in immunosuppression for renal transplantation. Kidney Int Suppl (1983) 0.93
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A. J Transplant (2012) 0.86
Effect of liver dysfunction on cyclosporine pharmacokinetics. Transplant Proc (1987) 0.86
Four decades of glucocorticosteroid immunosuppression. CMAJ (1992) 0.80
Steroids and modern immunosuppression. Br Med J (Clin Res Ed) (1983) 0.79
Past and future prospects of orthoptic liver transplantation. Arch Surg (1981) 0.79
Laryngeal transplantation: research, clinical experience, and future goals. Semin Plast Surg (2007) 0.78
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. Toxins (Basel) (2014) 0.77
Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants. Clin Transplant (1987) 0.75
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantation. Clin Exp Immunol (2002) 0.75
Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial. Transplant Proc (1982) 0.75
Cadaveric Renal Transplantation in Diabetics in the 1980's: with Special Reference to Cyclosporine. Diabet Nephrop (1983) 0.75
Cyclosporine. Kidney transplantation. Transplant Proc (1983) 0.75
Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A. Clin Exp Immunol (1991) 0.75
Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine. Transplant Proc (1983) 0.75
The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem (1970) 20.22
Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol (1966) 18.33
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions (1976) 9.68
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology (1977) 7.10
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
Immunologic characterization of human malignant lymphomas. Cancer (1974) 3.48
The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody. J Clin Pathol (1974) 3.41
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The unmasking of antigens in paraffin sections of tissue by trypsin. Experientia (1977) 3.34
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. N Engl J Med (1980) 1.68
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: an initial report. J Surg Res (1978) 1.60
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med (1978) 1.54
Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45
Cadaver donor renal transplantation by centers of the Southeastern Organ Procurement Foundation. Ann Surg (1981) 1.41
Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery (1978) 1.32
Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma. Lancet (1980) 1.31
The labeled antigen method of immunoenzymatic staining. J Histochem Cytochem (1979) 1.30
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N Engl J Med (1979) 1.07
Proceedings: The outcome of kidney retransplantation. Arch Surg (1974) 1.06
Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery (1979) 1.04
Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet (1981) 1.01
The impact of 1,000 renal transplants at one center. Ann Surg (1977) 0.91
Cyclosporin A and Epstein-Barr virus. Lancet (1980) 0.88
Measurement of kappa:lambda light chain ratios by haemagglutination techniques. J Immunol Methods (1975) 0.85
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell (1998) 6.48
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Induction of cellular DNA synthesis by polyoma virus. Proc Natl Acad Sci U S A (1965) 3.63
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34